Add to Calendar 11/4/2021 9:30:00 AM 11/4/2021 12:00:00 PM Digital Health Impact 2021

November 4, 2021              9:30 AM - 12 PM ET
The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities or collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients. Free virtual event
Virtual,
Senior Trade Officer, Canadian Technology Accelerator & Digital Health, Consulate General of Canada
Serban serves as the Senior Trade Officer for the CTA and Digital Health at the Consulate General of Canada in Boston. In his CTA managing role, he helps high-potential Canadian tech, life sciences and digital health start-ups connect to the New England market, clients, partners and investors, by providing the strategic guidance, market intelligence and network needed to compete in one of the world’s most dynamic ecosystems. As a physician entrepreneur with a strong clinical and research background, and extensive experience in healthcare innovation, Serban is focused on helping grow digital health and medical technologies in a global environment.

Brought to you by